Healthcare globalization: Impact on payor, provider, pharmaceuticals and life sciences

To stay competitive in today’s financial environment, payors, providers, pharmaceuticals and healthcare companies are increasingly reaching outside the United States for skills and services. As profit margins in the healthcare industry feel more pressure, lower middle market companies are forced to look for new areas to grow their top line and cut their cost structure. Many are looking to globalize their businesses. The experience of several Baird Private Equity companies in China and India illustrate the challenges and opportunities of healthcare globalization, and prove that these markets are equally accessible and potentially beneficial to lower middle market companies as they are to MNCs. Read the full article